Michael Dayton, founder and President of BIOMED, experienced in FDA regulatory matters since 1983, is well versed in various submission processes such as 510(k)s, IDEs, PMAs, DMFs, CE Technical Files, STED and Canadian MDLA. He has consulted with U.S. and European client companies ranging in size from start-ups to Fortune 500 companies.
Prior to forming BIOMED, Mr. Dayton served in senior management positions for medical device manufacturers, including LaserSight, Inc., MinTec, Inc., InterVascular, Inc., and Coburn Optical Industries / Revlon Vision Care. He holds Bachelor’s and Master’s degrees in the Biological Sciences, and performed his graduate internship at the U.S. Naval Aerospace Medical Research Laboratory.
His background provides him the analytical skills to address many technical problems that you, as a client, face in preparing your responses to FDA, Health Canada and Notified Bodies.
Contact Us Now for more information.